Skip to content

 

Clinical Research

Clinical research

Vertos Medical is committed to building the science behind its mild* procedure. Working with a scientific advisory board composed of clinical experts in pain medicine and neurosurgery, the company has developed a comprehensive clinical program to build a useful, robust collection of information regarding the safety of the mild procedure and the patient outcomes achieved following mild treatment. This program includes several postmarket clinical studies at leading pain centers across the country.

mild Postmarket Clinical Studies

Completed

  • High Risk Trial: 14-patient, single-site, open label, single-arm, prospective, IRB-approved study on high-risk patients.
  • ESI-I Trial: 38-patient, single-site, randomized, double-blind, prospective, IRB-approved study comparing mild and epidural steroid injections. Post-study follow-up ongoing.
    See press release on study findings   
  • Prospective Patient Series: 46-patient, single-site, open label, single-arm, prospective, IRB-approved study. Post-study follow-up ongoing.


Ongoing

  • MiDAS ECO: 100-patient, multi-site, randomized, IRB-approved study comparing mild and epidural steroid injections; now enrolling   

Fully detailed study methodologies are available upon request.


*Cleared by the U.S. Food and Drug Administration for lumbar decompression, Vertos mild is designed to treat lumbar spinal stenosis (LSS).